Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
GlaxoSmithKline
Age
50–any
Sex
MALE
Healthy volunteers
Not accepted
You may be eligible if
Any subject who has participated in the REDUCE Study and meets one of the following eligibility criteria is eligible for Part A, 2 Year Observational Follow-Up Study:
Completed 4 years on Investigational Product through the REDUCE 4 Year study visit (Visit 10) OR
Was diagnosed with prostate cancer during the REDUCE study, discontinued Investigational Product (IP) but participated in REDUCE Prostate Cancer Follow-Up visits through the 4 Year study visit (Visit 10P) OR
Withdrew from REDUCE study visit participation and IP (for any reasons) but participated in REDUCE Follow-Up phone calls every 6 months through the 4 Year phone call
Subjects eligible for enrolment in Part B of the study must meet the following criteria:
Any subject who was diagnosed with prostate cancer based on a prostate biopsy during participation in the REDUCE Study, regardless of when their REDUCE study participation ended.
You may not be if
Inability/unwillingness to participate in the Follow-Up Study phone calls.
Clareo Health | ARI103094-Follow-Up Study for REDUCE Study Subjects
